Sanofi SNY
$47.04 +$0.13 (+0.28%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $46.12 -1.96%
Open$45.63
Prev close$46.91
Day range$45.58 – $47.16
Volume3.90M
Market cap$112.71B
P/E (TTM)24.1
Dividend yield4.99%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€15.23B+15.7% YoY
Operating profit€4.71B+24.3% YoY
Net profit€3.03B+7.9% YoY
Diluted EPS€1.26+9.6% YoY
Free cash flow€5.17B-0.1% YoY
Operating cash flow€3.87B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin73.4%
Operating margin21.6%
Net margin8.2%
Return on equity5.7%
Return on assets3.2%
Return on invested capital4.8%
Current ratio1.12
Liabilities / assets43.8%
Cash & investments€5.97B
Total debt€19.63B
Net cash (debt)-€13.66B
Free cash flow / sales16.5%
Where the revenue comes from
Quarter 2026/Q2
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Operating Revenue | €15.23B | €12.30B | €11.24B | €46.72B | €12.21B |
| Cost of Revenue | €3.63B | €3.02B | €3.14B | €13.05B | €3.76B |
| Gross Profit | €11.60B | €9.28B | €8.11B | €33.67B | €8.45B |
| Operating Expense | €6.90B | €6.90B | €5.84B | €24.07B | €6.81B |
| Selling and Admin Expenses | €2.49B | €2.63B | €2.49B | €10.24B | €2.92B |
| -Selling & Marketing Expense | €180.00M | €169.00M | €167.00M | €699.00M | €178.00M |
| -General & Admin Expense | €2.31B | €2.47B | €2.33B | €9.54B | €2.75B |
| Research & Development | €1.85B | €2.23B | €1.75B | €7.84B | €2.29B |
| Depreciation & Amortization & Depletion | €556.00M | €552.00M | €535.00M | €1.78B | €538.00M |
| -Depreciation & Amortization | €556.00M | €552.00M | €535.00M | €1.78B | €538.00M |
| Other Operating Expenses | €2.00B | €1.48B | €1.06B | €4.21B | €1.06B |
| Operating Profit | €4.71B | €2.38B | €2.27B | €9.60B | €1.64B |
| Net Non-Operating Interest Income (Expense) | -€145.00M | -€210.00M | -€118.00M | -€129.00M | €161.00M |
| Non-Operating Interest Income | €77.00M | €77.00M | €60.00M | €331.00M | €33.00M |
| Non-Operating Interest Expense | €222.00M | €287.00M | €178.00M | €626.00M | €38.00M |
| Other Income (Expense) | -€356.00M | -€1.34B | -€148.00M | -€3.29B | -€2.72B |
| Special Income (Charges) | -€356.00M | -€1.34B | -€148.00M | -€3.25B | -€2.68B |
| -Less:Restructuring and Mergern & Acquisition | €96.00M | €516.00M | €84.00M | €1.24B | €523.00M |
| -Less:Impairment of Capital Assets | -€13.00M | €1.03B | €0.00 | €2.24B | €2.01B |
| -Less:Other Special Charges | €287.00M | -€7.00M | €102.00M | €255.00M | €198.00M |
| -Gain on Sale of Property/Plant/Equipment | €14.00M | €203.00M | €38.00M | €485.00M | €57.00M |
| Pretax Profit | €4.20B | €837.00M | €2.00B | €6.18B | -€917.00M |
| Tax | €1.20B | €451.00M | €420.00M | €1.04B | -€348.00M |
| Earnings from Equity Interest Net of Tax | €20.00M | -€9.00M | €11.00M | -€155.00M | -€238.00M |
| Net Profit | €3.03B | €377.00M | €1.62B | €7.85B | -€794.00M |
| Profit from Continuing Operations | €3.03B | €377.00M | €1.59B | €4.98B | -€807.00M |
| Net Income from Discontinuous Operations | €0.00 | €0.00 | €26.00M | €2.87B | €13.00M |
| Minority Interests | €8.00M | €34.00M | €6.00M | €38.00M | €7.00M |
| Net Income to Parent Company | €3.02B | €343.00M | €1.61B | €7.81B | -€801.00M |
| Net Income to Common Stockholders | €3.02B | €343.00M | €1.61B | €7.81B | -€801.00M |
| Basic EPS | €1.26 | €0.15 | €0.67 | €3.20 | -€0.33 |
| Diluted EPS | €1.26 | €0.14 | €0.67 | €3.19 | -€0.33 |
| Dividend Per Share | €0.00 | €2.07 | €0.00 | €1.94 | €0.00 |
| Total Other Finance Costs | – | – | – | -€166.00M | – |
| Gain on Sale of Security | – | – | – | -€40.00M | – |
| -Gain on Sale Of Business | – | – | – | €485.00M | €66.00M |
Balance sheet
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €130.29B | €129.06B | €128.02B | €126.81B | €126.81B |
| Total Current Assets | €33.21B | €31.52B | €30.16B | €30.95B | €30.95B |
| Cash and Cash Equivalents & Short-Term Investments | €5.97B | €6.35B | €5.54B | €8.47B | €8.47B |
| -Cash and Cash Equivalents | €5.97B | €6.35B | €5.54B | €7.66B | €7.66B |
| Receivables | €326.00M | €9.21B | €482.00M | €11.05B | €11.05B |
| -Taxes Receivable | €326.00M | €492.00M | €482.00M | €1.16B | €1.16B |
| Inventory | €25.02B | €11.13B | €23.50B | €10.21B | €10.21B |
| Total Non-Current Assets | €97.08B | €97.54B | €97.86B | €95.85B | €95.85B |
| Net PPE | €12.08B | €11.95B | €11.67B | €11.51B | €11.51B |
| -Gross PPE | €12.08B | €11.95B | €11.67B | €25.98B | €25.98B |
| Non Current Accounts Receivables | €585.00M | €569.00M | €556.00M | €793.00M | €793.00M |
| Goodwill and Other Intangible Assets | €67.63B | €68.31B | €69.09B | €67.56B | €67.56B |
| Other Non-Current Assets | €16.79B | €16.70B | €16.54B | – | – |
| Total Liabilities | €57.05B | €59.49B | €54.88B | €55.10B | €55.10B |
| Total Current Liabilities | €29.77B | €31.93B | €30.01B | €28.35B | €28.35B |
| Payables | €25.98B | €8.03B | €23.65B | €9.05B | €9.05B |
| -Accounts Payable | €24.55B | €7.15B | €22.71B | €7.36B | €7.36B |
| -Total Tax Payable | €1.43B | €884.00M | €942.00M | €1.12B | €1.12B |
| Short-Term Debt and Capital Lease Obligation | €3.57B | €7.25B | €6.18B | €4.61B | €4.61B |
| -Current Debt | €3.35B | €7.03B | €5.92B | €4.34B | €4.34B |
| -Current Capital Lease Obligation | €216.00M | €227.00M | €260.00M | €272.00M | €272.00M |
| Other Current Liabilities | €220.00M | €16.64B | €177.00M | €12.07B | €12.07B |
| Total Non-Current Liabilities | €27.28B | €27.56B | €24.87B | €26.75B | €26.75B |
| Long Term Accounts Payable and Other Payables | €2.15B | €3.83B | €2.14B | €3.64B | €3.64B |
| Long Term Debt and Capital Lease Obligation | €16.28B | €16.32B | €13.84B | €15.72B | €15.72B |
| -Long Term Debt | €14.59B | €14.65B | €12.30B | €14.25B | €14.25B |
| -Long Term Capital Lease Obligation | €1.69B | €1.68B | €1.54B | €1.47B | €1.47B |
| Non-Current Deferred Liabilities | €1.57B | €1.55B | €1.62B | €1.67B | €1.67B |
| Other Non-Current Liabilities | €7.28B | €1.26B | €7.27B | €1.09B | €1.09B |
| Total Equity | €73.24B | €69.57B | €73.14B | €71.71B | €71.71B |
| Stockholders' Equity | €72.88B | €69.21B | €72.81B | €71.38B | €71.38B |
| Minority Interests | €362.00M | €360.00M | €335.00M | €334.00M | €334.00M |
| -Accounts Receivable | – | €8.71B | – | €8.41B | €8.41B |
| Other Current Assets | – | €4.28B | – | – | – |
| Investments and Advances | – | €7.10B | – | €6.61B | €6.61B |
| -Available for Sale Securities | – | €2.80B | – | €2.59B | €2.59B |
| -Long Term Equity Investment | – | €3.21B | – | €2.93B | €2.93B |
| Financial Assets | – | €26.00M | – | €9.00M | €9.00M |
| Non-Current Note Receivables | – | €421.00M | – | €391.00M | €391.00M |
| Non-Current Prepaid Assets | – | €185.00M | – | €175.00M | €175.00M |
| -Goodwill | – | €41.95B | – | €41.30B | €41.30B |
| -Other Intangible Assets | – | €26.36B | – | €26.26B | €26.26B |
| Defined Pension Benefit | – | €203.00M | – | €194.00M | €194.00M |
| Non-Current Deferred Assets | – | €8.76B | – | €8.61B | €8.61B |
| Non-Current Liabilities | – | €4.59B | – | €4.54B | €4.54B |
| Capital Stock | – | €2.43B | – | €2.44B | €2.44B |
| -Common Stock | – | €2.43B | – | €2.44B | €2.44B |
| Additional Paid-In Capital | – | €0.00 | – | €1.00M | €1.00M |
| Less: Treasury Stock | – | €1.38B | – | €1.07B | €1.07B |
| Gains/Losses Not Affecting Retained Earnings | – | €62.40B | – | €64.44B | €64.44B |
| Other Equity Interests | – | €5.76B | – | €5.57B | €5.57B |
| -Short Term Investments | – | – | – | €810.00M | €810.00M |
| -Other Receivables | – | – | – | €1.48B | €1.48B |
| Prepaid Assets | – | – | – | €918.00M | €918.00M |
| -Accumulated Depreciation | – | – | – | -€14.47B | -€14.47B |
| -Other Payable | – | – | – | €560.00M | €560.00M |
| Current Provisions | – | – | – | €670.00M | €670.00M |
| Current Deferred Liabilities | – | – | – | €0.00 | €0.00 |
| Derivative Product Liabilities | – | – | – | €96.00M | €96.00M |
Cash flow
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | €3.87B | €2.96B | €1.68B | €10.75B | €3.45B |
| Net cash flow from continuing operations | €3.87B | €2.96B | €1.68B | €10.56B | €3.44B |
| Cash Flow from Discontinued Operating Activities | €0.00 | €0.00 | €0.00 | €189.00M | €2.00M |
| Net cash flow from investing | -€541.00M | -€365.00M | -€2.28B | -€2.45B | -€2.13B |
| Net Cash Flow from Continuing Investing Activities | -€536.00M | -€330.00M | -€2.09B | -€12.85B | -€1.91B |
| Net Other Investing Changes | -€2.93B | €2.06B | -€2.09B | -€80.00M | €10.86B |
| Financing Cash Flow | -€3.71B | -€1.81B | -€1.53B | -€8.21B | -€2.57B |
| Net Cash Flow from Continuing Financing Activities | -€3.71B | -€1.81B | -€1.53B | -€8.16B | -€2.57B |
| Net Other Financing Charges | -€7.02B | €1.50B | -€1.53B | -€38.00M | €5.55B |
| Cash Flow from Discontinued Financing Activities | €0.00 | €0.00 | €0.00 | -€48.00M | €0.00 |
| Ending Cash Balance | €5.97B | €6.35B | €5.54B | €7.66B | €7.66B |
| Net Change in Cash | -€383.00M | €790.00M | -€2.12B | €263.00M | -€1.26B |
| Beginning Cash Balance | €6.35B | €5.54B | €7.66B | €7.44B | €8.91B |
| Effect of Exchange Rate Changes | -€1.00M | €10.00M | €9.00M | -€47.00M | €7.00M |
| Free Cash Flow | €5.17B | €1.66B | €1.68B | €7.21B | -€93.00M |
| Net Income from Continuing Operations | – | – | – | €4.94B | – |
| Gain/Loss from Continuing Operations | – | – | – | €251.00M | – |
| Depreciation & Depletion & Amortization | – | – | – | €5.68B | – |
| Deferred Tax | – | – | – | -€2.44B | – |
| Other Non-Cash Items | – | – | – | €437.00M | – |
| Change in Working Capital | – | – | – | €1.80B | – |
| -Change in Receivables | – | – | – | -€1.20B | – |
| -Change in Inventory | – | – | – | -€39.00M | – |
| -Change in Payables and Accrued Expense | – | – | – | €398.00M | – |
| -Change In Other Working Capital | – | – | – | €2.64B | – |
| Net PPE Purchase and Sale | – | – | – | -€2.69B | – |
| Net Business Purchase and Sale | – | – | – | -€10.08B | – |
| Net Issuance Payments Of Debt | – | – | – | €1.50B | – |
| Net Common Stock Issuance | – | – | – | -€4.85B | – |
| Cash Dividends Paid | – | – | – | -€4.77B | – |
No comments yet — be the first to weigh in on SNY.
Sign in to join the discussion.